DEXTROSE 4.3 % AND SODIUM CHLORIDE 0.18 % INJECTION

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

GLUCOSE ANHYDROUS; SODIUM CHLORIDE

Disponível em:

NEOPHARM (ISRAEL) 1996 LTD

Código ATC:

B05BB01

Forma farmacêutica:

SOLUTION FOR INJECTION

Composição:

SODIUM CHLORIDE 0.18 G / 100 ML; GLUCOSE ANHYDROUS 4.3 G / 100 ML

Via de administração:

I.V

Tipo de prescrição:

Required

Fabricado por:

NEOPHARM (ISRAEL) LTD - CURE MEDICAL MANUFACTURING PLANT

Grupo terapêutico:

ELECTROLYTES

Área terapêutica:

ELECTROLYTES

Indicações terapêuticas:

Supply of water for administration of electrolytes or calories. Vehicle for therapeutic regimen.

Data de autorização:

2011-01-31

Características técnicas

NEOPHARM (ISRAEL) LTD. -
INTRAVENOUS INJECTIONS IN PLASTIC CONTAINERS
1. SINGLE ELECTROLYTE SOLUTIONS
1. 0.45% Sodium Chloride Injection.
2. SINGLE ELECTROLYTE SOLUTIONS WITH DEXTROSE
1. 3.3% Dextrose and 0.3% Sodium Chloride Injection.
2. 4.3% Dextrose and 0.18% Sodium Chloride Injection.
3. 5% Dextrose and 0.33% Sodium Chloride Injection.
4. 5% Dextrose and 0.45% Sodium Chloride Injection.
5.
5% Dextrose and 0.9% Sodium Chloride Injection.
3. MULTIPLE ELECTROLYTE SOLUTIONS WITH DEXTROSE
1. 5% Dextrose and 0.3% Sodium Chloride and 0.15% Potassium Chloride
Injection.
DESCRIPTION
Intravenous solutions are sterile, nonpyrogenic and contain no
bacteriostatic or antimicrobial agents or added buffers.
The composition, osmolarity and approx. pH values of the individual
solutions are shown in
Table 1.
ACTIONS
Intravenous solutions provide electrolytes and/or calories, and are a
source of water for hydration. All are capable of
inducing diuresis depending on the clinical condition of the patient.
Solutions containing dextrose provide calories. See
Table 2 for calories per liter of the various solutions.
Solutions which are di-electrolytic or polyelectrolytic have value in
maintaining or replenishing electrolytes. See Table 2
for ionic concentrations.
INDICATIONS

Supply of water, for administration of electrolytes or calories.

Vehicle for therapeutic regimen.
CONTRAINDICATIONS
Excess body water volume.
Diabetic coma with excessively high blood sugar (solutions containing
glucose).
Hypovolaemia.
Cardiac insufficiency.
Edema, ascites ( cirrhosis related syndrome).
WARNINGS
Dispensing without a doctor's prescription is prohibited.
The administration of Intravenous Injections can cause fluid and/or
solute overloading resulting in dilution of serum
electrolyte concentrations, overhydration, congestive conditions, or
pulmonary edema. The risk of serum dilution is
inversely proportional to the electrolyte concentrations of the
injections.
The risk of solute overload causing congestion with peripheral and
pulmonary edema